HomeInsights52 Week Low Stocks

Emcure Pharmaceuticals Ltd 52 Week Low

Emcure Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

4.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

YEARLOW

₹ 1226.5

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week Low of Emcure Pharmaceuticals Ltd is ₹ 1226 as of 22 Nov 24 .

Company Fundamentals for Emcure Pharmaceuticals Ltd

No data available

Market Price of Emcure Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241313.6
21 Nov 20241284.2
19 Nov 20241306.05
18 Nov 20241310.5
14 Nov 20241358.75
13 Nov 20241333.85
12 Nov 20241399.15
11 Nov 20241432.65
08 Nov 20241396.85
07 Nov 20241437.35

Asset Value vs Market Value of Emcure Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Emcure Pharmaceuticals Ltd News Hub

News

Emcure Pharmaceuticals allots 3.33 lakh equity shares under ESOS

Emcure Pharmaceuticals has allotted 3,33,500 equity shares under ESOS on 22 November 2024....

Read more

22 Nov 202417:56

News

Emcure Pharma Q2 PAT rises 38.2% YoY

In Q2FY25, the drug maker's consolidated revenue from operations stood at Rs 2,002 crore, ...

Read more

08 Nov 202412:50

News

Emcure Pharmaceuticals to hold board meeting

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...

Read more

02 Nov 202413:58

News

Emcure Pharmaceuticals to announce Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...

Read more

31 Oct 202410:43

News

Emcure signs licensing agreement with Gilead Sciences

Emcure Pharmaceuticals announced the signing of a royalty-free voluntary licensing agreeme...

Read more

03 Oct 202410:15

News

Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities

Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigne...

Read more

13 Aug 202419:01

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Emcure Pharmaceuticals Ltd

Why is it important to track the 52-week low of Emcure Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Emcure Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Emcure Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Emcure Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Emcure Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Emcure Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Emcure Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Emcure Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Emcure Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Emcure Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Emcure Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Emcure Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Emcure Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*